Back to Search
Start Over
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
- Source :
-
Investigational new drugs [Invest New Drugs] 1994; Vol. 12 (3), pp. 259-61. - Publication Year :
- 1994
- Subjects :
- Antimetabolites, Antineoplastic adverse effects
Hematologic Diseases chemically induced
Humans
Middle Aged
Nausea chemically induced
Neoplasm Metastasis
Sleep Stages
Vidarabine Phosphate adverse effects
Vidarabine Phosphate therapeutic use
Antimetabolites, Antineoplastic therapeutic use
Sarcoma drug therapy
Vidarabine Phosphate analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 0167-6997
- Volume :
- 12
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Investigational new drugs
- Publication Type :
- Academic Journal
- Accession number :
- 7534752
- Full Text :
- https://doi.org/10.1007/BF00873969